Wegovy

The recent data from the STEER real-world study of evidence gathered from actual patient experiences at the European Society of…

Doctors have warned of the risk of overuse and misuse, cautioning that patients will see such medications as an easy, quick fix,…

GlobalData’s report reveals that the US will contribute the most to the growth of the HF market due to the higher prevalence of HF…

Recently, Eli Lilly announced the results from its SURMOUNT-5 trial, comparing Zepbound and Wegovy’s efficacy on equal grounds

The survey included 2,205 adults and was conducted on September 5, 2024

The drug will not be subsidised under the Pharmaceutical Benefits Scheme

Semaglutide is the first weight loss drug approved in the UK as a preventative treatment for those with established cardiovascular…

According to GlobalData, there are over 50 clinical trials for type 2 diabetes or obesity treatment involving GLP-1R agonists

Shift could reflect a changing demand away from oncology toward addressing metabolic disorders

Four companies – Lilly (59.2 per cent), Novo Nordisk (51.5 per cent), Vertex Pharmaceuticals (41.4 per cent) and Regeneron…